Movement Disorders

Optimal Management of OFF Episodes in Parkinson Disease

Experts review the challenges of managing OFF episodes in Parkinson disease and the current treatment options to optimize therapy.

Episode 21: How Social Isolation Can Affect Disease Severity

"Mind Moments," a podcast from NeurologyLive, brings you an exclusive interview with Indu Subramanian, MD.

Dietary Vitamin C and E Associated with Lower Risk of Parkinson Disease

January 18, 2021

Article

Further associations with lowered risk of Parkinson were observed with BMI and coffee intake.

This Week on NeurologyLive — January 18, 2020

January 18, 2021

Article

Here's what is coming soon to NeurologyLive.

Raymond Sanchez, MD: Phase 2 Trial Data of Tavapadon in Parkinson Disease

January 16, 2021

Video

The chief medical officer of Cerevel Therapeutics detailed phase 2 data of its investigational agent tavapadon, which has been studied in patients with Parkinson disease.

NeurologyLive Friday 5 — January 15, 2021

January 15, 2021

Article

Take 5 minutes to catch up on NeurologyLive's highlights from the week ending January 15, 2021.

MIND Diet Effective in Delaying Parkinson Onset in Women

January 13, 2021

Article

Men were observed to derive benefit from a Greek Mediterranean diet and women were found to generally adhere more closely to diet interventions than men.

NeuroVoices: Fabio Nascimento, MD, on Improving EEG Education in Residency Programs

January 13, 2021

Article

The clinical fellow at Massachusetts General Hospital detailed his research on neurology resident EEG education, and the increased need for more consistency throughout programs.

Michael Okun, MD: Long-Term Plan for Modifying Neurologic Device Approval System

January 12, 2021

Video

The executive director of the Norman Fixel Institute for Neurological Diseases gave his call-to-action on how to change the approval system for neurologic devices for rare diseases.

This Week on NeurologyLive — January 11, 2020

January 11, 2021

Article

Here's what is coming soon to NeurologyLive.

Raymond Sanchez, MD: Phase 3 TEMPO Trials Guide Tavapadon

January 10, 2021

Video

The chief medical officer of Cerevel Therapeutics detailed the TEMPO trials, a trio of studies that will examine tavapadon in patients with early and late-stage Parkinson disease.

NeurologyLive Friday 5 — January 8, 2021

January 08, 2021

Article

Take 5 minutes to catch up on NeurologyLive's highlights from the week ending January 8, 2021.